<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d415" origId="L-Glutamine"><sentence id="DrugDDI.d415.s0" origId="s0" text="Human growth hormone - Concomitant use of L-glutamine and human growth hormone may enhance nutrient absorption in those with severe short bowel syndrome."><entity id="DrugDDI.d415.s0.e0" origId="s0.p0" charOffset="0-20" type="drug" text="Human growth hormone"/><entity id="DrugDDI.d415.s0.e1" origId="s0.p1" charOffset="44-53" type="drug" text="glutamine"/><entity id="DrugDDI.d415.s0.e2" origId="s0.p3" charOffset="58-78" type="drug" text="human growth hormone"/><pair id="DrugDDI.d415.s0.p0" e1="DrugDDI.d415.s0.e0" e2="DrugDDI.d415.s0.e1" interaction="false"/><pair id="DrugDDI.d415.s0.p1" e1="DrugDDI.d415.s0.e0" e2="DrugDDI.d415.s0.e2" interaction="false"/><pair id="DrugDDI.d415.s0.p2" e1="DrugDDI.d415.s0.e1" e2="DrugDDI.d415.s0.e2" interaction="true"/></sentence><sentence id="DrugDDI.d415.s1" origId="s1" text="L-glutamine has orphan drug status for this indication."><entity id="DrugDDI.d415.s1.e0" origId="s1.p8" charOffset="0-11" type="drug" text="L-glutamine"/><entity id="DrugDDI.d415.s1.e1" origId="s1.p10" charOffset="16-27" type="drug" text="orphan drug"/><pair id="DrugDDI.d415.s1.p0" e1="DrugDDI.d415.s1.e0" e2="DrugDDI.d415.s1.e1" interaction="false"/></sentence><sentence id="DrugDDI.d415.s2" origId="s2" text="Indomethacin - Concomitant use of L-glutamine and indomethacin may ameliorate increased intestinal permeability caused by indomethacin."><entity id="DrugDDI.d415.s2.e0" origId="s2.p12" charOffset="0-12" type="drug" text="Indomethacin"/><entity id="DrugDDI.d415.s2.e1" origId="s2.p13" charOffset="36-45" type="drug" text="glutamine"/><entity id="DrugDDI.d415.s2.e2" origId="s2.p15" charOffset="50-62" type="drug" text="indomethacin"/><entity id="DrugDDI.d415.s2.e3" origId="s2.p20" charOffset="122-134" type="drug" text="indomethacin"/><pair id="DrugDDI.d415.s2.p0" e1="DrugDDI.d415.s2.e0" e2="DrugDDI.d415.s2.e1" interaction="false"/><pair id="DrugDDI.d415.s2.p1" e1="DrugDDI.d415.s2.e0" e2="DrugDDI.d415.s2.e2" interaction="false"/><pair id="DrugDDI.d415.s2.p2" e1="DrugDDI.d415.s2.e0" e2="DrugDDI.d415.s2.e3" interaction="false"/><pair id="DrugDDI.d415.s2.p3" e1="DrugDDI.d415.s2.e1" e2="DrugDDI.d415.s2.e2" interaction="true"/><pair id="DrugDDI.d415.s2.p4" e1="DrugDDI.d415.s2.e1" e2="DrugDDI.d415.s2.e3" interaction="false"/><pair id="DrugDDI.d415.s2.p5" e1="DrugDDI.d415.s2.e2" e2="DrugDDI.d415.s2.e3" interaction="false"/></sentence><sentence id="DrugDDI.d415.s3" origId="s3" text="The reported dose used for L-glutamine was 21 grams daily taken in divided doses three times a day."><entity id="DrugDDI.d415.s3.e0" origId="s3.p23" charOffset="29-38" type="drug" text="glutamine"/></sentence><sentence id="DrugDDI.d415.s4" origId="s4" text="Further, misoprostol is reported to have a synergistic effect with this combination in ameliorating intestinal permeability."><entity id="DrugDDI.d415.s4.e0" origId="s4.p30" charOffset="9-20" type="drug" text="misoprostol"/></sentence><sentence id="DrugDDI.d415.s5" origId="s5" text="Methotrexate - There is one report that methotrexate may decrease the possible effectiveness of supplemental L-glutamine for chemotherapy-induced mucositis."><entity id="DrugDDI.d415.s5.e0" origId="s5.p38" charOffset="0-12" type="drug" text="Methotrexate"/><entity id="DrugDDI.d415.s5.e1" origId="s5.p42" charOffset="40-52" type="drug" text="methotrexate"/><entity id="DrugDDI.d415.s5.e2" origId="s5.p46" charOffset="111-120" type="drug" text="glutamine"/><pair id="DrugDDI.d415.s5.p0" e1="DrugDDI.d415.s5.e0" e2="DrugDDI.d415.s5.e1" interaction="false"/><pair id="DrugDDI.d415.s5.p1" e1="DrugDDI.d415.s5.e0" e2="DrugDDI.d415.s5.e2" interaction="false"/><pair id="DrugDDI.d415.s5.p2" e1="DrugDDI.d415.s5.e1" e2="DrugDDI.d415.s5.e2" interaction="false"/></sentence><sentence id="DrugDDI.d415.s6" origId="s6" text="In another report, nine patients with breast cancer were reported to have decreased symptoms of methotrexate-related toxicity when given supplemental L-glutamine at a dose of 0.5 gram/kilogram/day."><entity id="DrugDDI.d415.s6.e0" origId="s6.p58" charOffset="152-161" type="drug" text="glutamine"/></sentence><sentence id="DrugDDI.d415.s7" origId="s7" text="Paclitaxel - In one report, L-glutamine at a dose of 10 grams three times daily, given 24 hours after receiving paclitaxel, appeared to prevent the development of myalgia and arthralgia, adverse reactions of paclitaxel."><entity id="DrugDDI.d415.s7.e0" origId="s7.p63" charOffset="0-10" type="drug" text="Paclitaxel"/><entity id="DrugDDI.d415.s7.e1" origId="s7.p65" charOffset="28-39" type="drug" text="L-glutamine"/><entity id="DrugDDI.d415.s7.e2" origId="s7.p70" charOffset="112-122" type="drug" text="paclitaxel"/><entity id="DrugDDI.d415.s7.e3" origId="s7.p73" charOffset="136-143" type="drug" text="prevent"/><entity id="DrugDDI.d415.s7.e4" origId="s7.p79" charOffset="208-218" type="drug" text="paclitaxel"/><pair id="DrugDDI.d415.s7.p0" e1="DrugDDI.d415.s7.e0" e2="DrugDDI.d415.s7.e1" interaction="false"/><pair id="DrugDDI.d415.s7.p1" e1="DrugDDI.d415.s7.e0" e2="DrugDDI.d415.s7.e2" interaction="false"/><pair id="DrugDDI.d415.s7.p2" e1="DrugDDI.d415.s7.e0" e2="DrugDDI.d415.s7.e3" interaction="false"/><pair id="DrugDDI.d415.s7.p3" e1="DrugDDI.d415.s7.e0" e2="DrugDDI.d415.s7.e4" interaction="false"/><pair id="DrugDDI.d415.s7.p4" e1="DrugDDI.d415.s7.e1" e2="DrugDDI.d415.s7.e2" interaction="true"/><pair id="DrugDDI.d415.s7.p5" e1="DrugDDI.d415.s7.e1" e2="DrugDDI.d415.s7.e3" interaction="false"/><pair id="DrugDDI.d415.s7.p6" e1="DrugDDI.d415.s7.e1" e2="DrugDDI.d415.s7.e4" interaction="false"/><pair id="DrugDDI.d415.s7.p7" e1="DrugDDI.d415.s7.e2" e2="DrugDDI.d415.s7.e3" interaction="false"/><pair id="DrugDDI.d415.s7.p8" e1="DrugDDI.d415.s7.e2" e2="DrugDDI.d415.s7.e4" interaction="false"/><pair id="DrugDDI.d415.s7.p9" e1="DrugDDI.d415.s7.e3" e2="DrugDDI.d415.s7.e4" interaction="false"/></sentence></document>